LPL Financial LLC

Position in CAPR — Capricor Therapeutics, Inc.

CIK 1403438 FORT MILL, SC

Position in CAPR

as of Mar 31, 2026 · filed May 6, 2026 Compact

Position Value

$851,260

-$493,644 QoQ

Shares Held

28,002

-39.9% QoQ

Ownership

0.048%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2023

10 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

LPL Financial LLC holds $467,195,563 across 201 Biotechnology names. CAPR ranks #61 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	268,062	$119,700,405
2	REGN	Regeneron Pharmaceuticals, Inc.	63,987	$49,438,915
3	INSM	INSMED Inc	138,281	$22,611,709
4	ALNY	Alnylam Pharmaceuticals, Inc.	67,637	$22,379,054
5	EXEL	Exelixis, Inc.	399,612	$17,139,358
6	ARGX	Argenx SE	23,247	$16,976,121
7	HALO	Halozyme Therapeutics, Inc.	194,304	$12,557,867
8	ROIV	Roivant Sciences Ltd.	378,656	$10,488,771

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$851,260	28,002	-39.9%	Shares	Sole	2026-05-06
2025-12-31	$1,344,904	46,601	+9.1%	Shares	Sole	2026-02-11
2025-09-30	$307,874	42,701	+141.0%	Shares	Sole	2025-11-12
2025-06-30	$175,969	17,721	+77.2%	Shares	Sole	2025-08-12
2024-09-30	$152,115	10,001	-68.7%	Shares	Sole	2024-11-08
2024-06-30	$152,582	31,988	-31.0%	Shares	Sole	2024-08-07
2024-03-31	$314,635	46,338	-40.8%	Shares	Sole	2024-05-10
2023-12-31	$382,583	78,238	-3.7%	Shares	Sole	2024-02-14
2023-09-30	$277,833	81,238	+3.6%	Shares	Sole	2023-11-13
2023-06-30	$374,924	78,436	—	Shares	Sole	2023-07-31
No filing history on record for this holder in this stock.